{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:09:04Z","timestamp":1791486544571,"version":"4.3.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12185-023-03531-z","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T17:02:52Z","timestamp":1674579772000},"page":"929-932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dasatinib for chronic myelomonocytic leukemia with ZMIZ1-ABL1 fusion gene: a case report"],"prefix":"10.1007","volume":"117","author":[{"given":"Heng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"issue":"1","key":"3531_CR1","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.clml.2020.08.011","volume":"21","author":"V Yadav","year":"2021","unstructured":"Yadav V, Ganesan P, Veeramani R, Kumar VD. Philadelphia-like acute lymphoblastic leukemia: a systematic review. Clin Lymphoma Myeloma Leuk. 2021;21(1):e57\u201365. https:\/\/doi.org\/10.1016\/j.clml.2020.08.011.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"3531_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0609.2011.01586.x","volume":"86","author":"E De Braekeleer","year":"2011","unstructured":"De Braekeleer E, Douet-Guilbert N, Rowe D, Bown N, Morel F, Berthou C, et al. ABL1 fusion genes in hematological malignancies: a review. Eur J Haematol. 2011;86(5):361\u201371. https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01586.x.","journal-title":"Eur J Haematol"},{"issue":"5\u20136","key":"3531_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/1947601912458584","volume":"3","author":"O Hantschel","year":"2012","unstructured":"Hantschel O. Structure, regulation, signaling, and targeting of abl kinases in cancer. Genes Cancer. 2012;3(5\u20136):436\u201346. https:\/\/doi.org\/10.1177\/1947601912458584.","journal-title":"Genes Cancer"},{"key":"3531_CR4","doi-asserted-by":"publisher","unstructured":"Soler G, Radford-Weiss I, Ben-Abdelali R, Mahlaoui N, Ponceau JF, Macintyre EA et al. Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation. Leukemia. 2008; 22(6):1278\u201380. https:\/\/doi.org\/10.1038\/sj.leu.2405033.","DOI":"10.1038\/sj.leu.2405033"},{"issue":"20","key":"3531_CR5","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544.","journal-title":"Blood"},{"issue":"13","key":"3531_CR6","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1093\/nar\/gkm476","volume":"35","author":"J Lee","year":"2007","unstructured":"Lee J, Beliakoff J, Sun Z. The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor. Nucleic Acids Res. 2007;35(13):4523\u201334. https:\/\/doi.org\/10.1093\/nar\/gkm476.","journal-title":"Nucleic Acids Res"},{"issue":"33","key":"3531_CR7","doi-asserted-by":"publisher","first-page":"23748","DOI":"10.1074\/jbc.M508365200","volume":"281","author":"X Li","year":"2006","unstructured":"Li X, Thyssen G, Beliakoff J, Sun Z. The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. J Biol Chem. 2006;281(33):23748\u201356. https:\/\/doi.org\/10.1074\/jbc.M508365200.","journal-title":"J Biol Chem"},{"issue":"5","key":"3531_CR8","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.immuni.2015.10.007","volume":"43","author":"N Pinnell","year":"2015","unstructured":"Pinnell N, Yan R, Cho HJ, Keeley T, Murai MJ, Liu Y, et al. The PIAS-like coactivator Zmiz1 is a direct and selective cofactor of Notch1 in T cell development and leukemia. Immunity. 2015;43(5):870\u201383. https:\/\/doi.org\/10.1016\/j.immuni.2015.10.007.","journal-title":"Immunity"},{"issue":"1","key":"3531_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s0959-437x(05)80338-7","volume":"3","author":"JY Wang","year":"1993","unstructured":"Wang JY. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr Opin Genet Dev. 1993;3(1):35\u201343. https:\/\/doi.org\/10.1016\/s0959-437x(05)80338-7.","journal-title":"Curr Opin Genet Dev"},{"issue":"8","key":"3531_CR10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.leukres.2009.03.011","volume":"33","author":"R Nand","year":"2009","unstructured":"Nand R, Bryke C, Kroft SH, Divgi A, Bredeson C, Atallah E. Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors. Leuk Res. 2009;33(8):1144\u20136. https:\/\/doi.org\/10.1016\/j.leukres.2009.03.011.","journal-title":"Leuk Res"},{"issue":"11","key":"3531_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371(11):1005\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1403088.","journal-title":"N Engl J Med"},{"issue":"1","key":"3531_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ajh.25684","volume":"95","author":"MM Patnaik","year":"2020","unstructured":"Patnaik MM, Tefferi A. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management. Am J Hematol. 2020;95(1):97\u2013115. https:\/\/doi.org\/10.1002\/ajh.25684.","journal-title":"Am J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03531-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03531-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03531-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,28]],"date-time":"2023-05-28T12:03:03Z","timestamp":1685275383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03531-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3531"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03531-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no financial disclosures relating to this manuscript and this research was conducted with no grant support or external assistance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975 (in its most recently amended version). Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}